News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Opexa Therapeutics (OPXA) CEO Invited Panelist at 9th Annual Burrill Personalized Medicine Meeting


9/30/2013 7:40:53 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing Tcelna®, a patient-specific T-cell immunotherapy for the treatment of multiple sclerosis (MS), today announced that Neil K. Warma, Opexa’s President and Chief Executive Officer, has been invited as a panel member to participate in the 9th Annual Burrill Personalized Medicine Meeting. The event will take place September 30 - October 1, 2013 at the Bently Reserve & Conference Center in San Francisco.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES